particularly within the frontal and premotor areas, is improved by subthalamic nucleus stimulation. This study examined changes in cortical activity, as reflected in the CNV, associated with bilateral subthalamic
Introduction
Parkinson's disease has been generally considered purely a outflow of the globus pallidus internus (GPi) and substantia nigra pars reticulata (SNr) to the thalamus, and hence reduced movement disorder in which cognitive functions remain largely unimpaired. It is now clear, however, that it involves outflow to the cortex (Wichmann and DeLong, 1996) . Five parallel, segregated circuits have been identified deficits in cognitive executive function, including deficits in planning, working memory and the allocation of attention, passing through the basal ganglia and thalamus, originating and terminating in discrete cortical areas (Alexander et al., as well as visuospatial deficits (Brown et al., 1997; Dubois and Pillon, 1997) . Such cognitive deficits are probably linked 1990). In particular, a motor circuit links the supplementary motor area of the cortex, the putamen and the ventrolateral to impaired frontal cortex function. Parkinson's disease involves a loss of dopaminergic neurons of the substantia portion of GPi, while a 'dorsolateral prefrontal' circuit links the dorsolateral prefrontal cortex (Brodmann areas 9 and nigra pars compacta, severely impairing dopaminergic input to the putamen of the basal ganglia. According to the 10), the dorsolateral head of the caudate and the lateral dorsomedial portion of GPi. The supplementary motor area model of basal ganglia-thalamocortical circuitry proposed by Wichmann and DeLong, this leads to excessive inhibitory and dorsolateral prefrontal cortex are therefore both linked with basal ganglia function via discrete basal gangliafrom the primary sensorimotor, temporal and occipital areas during the later phase (Hamano et al., 1997) . There is also thalamocortical circuits.
In Parkinson's disease, activity of both the supplementary debate over the extent to which the late component of the CNV and the Bereitschaftspotential reflect different motor area and the dorsolateral prefrontal cortex is found to be significantly impaired during movement (Playford et al., processes, particularly for movement tasks with differing anticipatory and/or strategic components (Cunnington et al., 1992; Jahanshahi et al., 1995) . Outflow of the right GPi has also been found to be impaired in Parkinson's disease patients 1999). Nonetheless, it is clear that activity of the prefrontal cortex contributes to the amplitude of the CNV. during cognitive tasks known to involve the prefrontal cortex (Owen et al., 1998) . Impaired activation of the supplementary
The amplitude of the CNV is significantly reduced in Parkinson's disease patients compared with controls (Wright motor area is improved following treatment with levodopa (Rascol et al., 1994) and apomorphine (Jenkins et al., 1992; Praamstra et al., 1996; Pulvermüller et al., 1996; Ikeda et al., 1997; Wascher et al., 1997) , although the Rascol et al., 1992) , both of which act to increase striatal dopamine levels and improve basal ganglia outflow.
topography and extent of CNV impairment vary considerably depending upon the task employed. Ikeda and colleagues Posteroventral pallidotomy (Samuel et al., 1997) and highfrequency electrical stimulation of the subthalamic nucleus found that the level of CNV reduction in Parkinson's disease patients, particularly over the frontal areas, is directly related , both aimed at reducing the excessive inhibitory outflow from the globus pallidus and thereby to the severity of disease (Ikeda et al., 1997) , and the amplitude of the CNV has been shown to increase following increasing basal ganglia-thalamic outflow to the cortex, also result in improved activation of the supplementary motor treatment with levodopa (Amabile et al., 1986; Oishi et al., 1995) . This suggests that the CNV amplitude is closely area and the dorsolateral prefrontal cortex during movement [although stimulation of GPi showed no effect on cortical linked with basal ganglia functioning. Ikeda and colleagues suggest that the cortical-basal ganglia-thalamocortical circuit activation during movement ]. These studies highlight the important link between basal ganglia plays a major role in the generation of the CNV (Ikeda et al., 1997) , based on evidence from animal studies of function and frontal cortex function, particularly within the supplementary and dorsolateral prefrontal areas.
'behaviourally contingent activity', equivalent to the CNV, found in neurons within areas of the putamen, globus pallidus Deficits in frontal cortex function in Parkinson's disease patients have also been studied electrophysiologically by and thalamus that project to the supplementary motor and prefrontal cortical areas (Kimura, 1986 (Kimura, , 1990 ; Jinnai et al., examining event-related potentials such as the Bereitschaftspotential and contingent negative variation (CNV).
1993). The aim of this study was to investigate further the The Bereitschaftspotential (Kornhuber and Deecke, 1965 ) is a slow negative shift in the EEG that begins 1-2 s prior to relationship between basal ganglia and cortical functioning in Parkinson's disease by examining the nature of deficits in voluntary movement, and is thought to reflect processes associated with the preparation for voluntary movement, the CNV for patients when on compared with off highfrequency stimulation of the subthalamic nucleus. Surgical involving the supplementary motor area and the primary motor cortex. The amplitude of the early Bereitprocedures such as lesioning or stimulation of the subthalamic nucleus or GPi are now used commonly in the treatment of schaftspotential is greatly reduced in patients with Parkinson's disease (Deecke and Kornhuber, 1978; Dick et al., 1989;  Parkinson's disease. Theoretically, these procedures aim to reduce the excessive inhibitory outflow of the GPi/SNr, and Cunnington et al., 1995 Cunnington et al., , 1997 , but is improved following treatment with levodopa (Dick et al., 1987) , and therefore thereby to increase the basal ganglia-thalamic outflow to the cortex. Continuous high-frequency stimulation appears to probably reflects impairment of the 'motor' loop of the basal ganglia-thalamocortical circuitry as defined by Wichmann inhibit the target region, producing an effect similar to a lesion (Benazzouz et al., 1995 (Benazzouz et al., , 1996 , but has the advantage and DeLong (Wichmann and DeLong, 1996) .
The CNV is also a slow negative shift in EEG that occurs that the effect is reversible and may be modified by altering the stimulation parameters. Surgical intervention at the level between a warning stimulus and an imperative stimulus (Walter et al., 1964) , and is thought to reflect cognitive of the subthalamic nucleus could theoretically be more effective than intervention at the level of the pallidum, since processes associated with planning and/or anticipation of the response to the imperative stimulus. The CNV is distributed it could affect the activity of the SNr as well as of the GPi. Indeed, it has been shown that, compared with stimulation widely over the scalp, with the maximum amplitude usually recorded at frontal and central electrodes. It is clear that of the GPi, subthalamic nucleus stimulation leads to greater improvement of cortical activity during movement (Limousin activity of the frontal cortex contributes to the CNV. Oishi and Mochizuki showed recently that the amplitude of the et al., 1997) as well as greater clinical improvement in motor symptoms (Krack et al., 1998) . CNV was significantly correlated with blood flow only within the frontal cortex (Oishi and Mochizuki, 1998) . Hamano and In this study, Parkinson's disease patients with stimulators implanted bilaterally within the subthalamic nuclei of both colleagues, using subdural electrode recordings, localized the early component of the CNV to the prefrontal cortex and hemispheres were examined when both on and off stimulation, and were compared with age-matched control subjects. The supplementary motor area, but with additional contributions CNV was examined as an index of basal gangliaand all experimental work was carried out with the approval of the Ethics Committee of the General Hospital of Vienna. thalamocortical functioning, in order to examine the effectiveness of subthalamic nucleus stimulation in improving cortical functioning in Parkinson's disease.
Procedure
Subjects performed a bilateral Go/NoGo choice reaction time
Methods
task in which a pair of tones was presented via headphones. A low-frequency (1000 Hz, duration ϭ 20 ms) warning
Subjects
Ten patients with Parkinson's disease (six male, four female), stimulus was first presented, and was followed exactly 2 s later by an imperative stimulus consisting either of a highaged between 38 and 68 years (mean ϭ 55.9 years), and 10 healthy control subjects (six male, four female; mean age ϭ frequency (2000 Hz, 20 ms) or a medium-frequency tone (1500 Hz, 20 ms), representing NoGo and Go signals, 45.1 years) participated in the study. All Parkinson's disease patients had chronic bilateral electrodes (Medtronic Inc., respectively. Subjects rested the index finger of both hands on buttons mounted on the arm-rests of the EEG chair Minneapolis, Minn., USA) implanted in the subthalamic nucleus of both hemispheres. Electrodes had been placed by and were instructed to press both left and right buttons simultaneously upon presentation of the medium-frequency stereotaxic guidance, with the target identified by both MRI and ventriculography (Alesch et al., 1995) . Stimulation tone (Go stimulus), but to withhold responses to the highfrequency tone (NoGo stimulus). Go and NoGo stimuli were parameters (Table 1) had been set individually for optimal clinical benefit.
given with equal probability of occurrence (i.e. equal numbers over the entire study), but the order of presentation varied All patients remained on their normal anti-Parkinsonian medication throughout the study (Table 1) . Clinical randomly between trials. The warning stimulus for the subsequent trial was given 5 s after the imperative stimulus assessment was performed immediately prior to on-and offstimulation sessions using the motor section of the Unified for the preceding trial. Two recording sessions were completed, each consisting Parkinson's Disease Rating Scale (UPDRS). Stimulation was clearly effective for every patient (Table 1) ; hence, a of 200 trials and lasting~25 min, with an interval of~20 min between sessions. The two sessions were equivalent for significant improvement in clinical state was found when patients were on stimulation (mean motor UPDRS ϭ 25.9) control subjects in order to examine effects due to practice or fatigue across sessions, while Parkinson's disease subjects compared with off stimulation (mean motor UPDRS ϭ 45.5) [t(9) ϭ 5.98, P Ͻ 0.001].
were tested with stimulation on during the first session and stimulation off during the second session. All patients had All subjects gave their informed consent prior to participation in accordance with the Declaration of Helsinki, their stimulators switched off immediately after completing the first session, and clinical assessment of patients with and the last third of trials for both conditions. Mean amplitudes of these potentials were examined using analysis stimulators off was carried out immediately before beginning the second session.
of Average waveforms of the CNV across the different electrode orbital rim of the right eye) were also recorded.
positions are shown for control subjects in Fig. 1 and for Non-polarizable Ag/AgCl electrodes were connected to Parkinson's disease subjects in Fig. 2 . A negative potential the scalp via salt bridges (silicon rubber filled with electrode shift, beginning within 200 ms after the warning stimulus gel) in order to reduce skin potentials and to stabilize and increasing slowly until the time of the imperative electrode potentials (Bauer et al., 1989) . Electrode sites were stimulus, was present for both Parkinson's disease and control prepared with a conductive abrasive solution to reduce subjects. This negative shift was particularly pronounced electrode impedance at 5 Hz to Ͻ5 kΩ. A computer-based over the frontal and central electrode sites for control subjects multichannel DC amplifier with digital filtering (Lindinger and Parkinson's disease patients when on stimulation, but et al., 1991) was used. Data were digitized at 250 Hz using appeared greatly reduced in patients off stimulation. a bandpass ranging from DC to 100 Hz. During off-line Overall analysis of variance showed a significant four-way processing, eye-blink artefacts were detected in EOG channels interaction between electrode position, time interval, session/ and corrected in EEG channels using a linear regression stimulation and subject group [F(54,972) ϭ 1.617, P Ͻ 0.01]; method (Jervis et al., 1988) . Data for every channel were therefore, results for Parkinson's disease and control subjects then inspected manually for further artefacts. Trials in which were analysed separately. Control subjects showed a the majority of channels were affected by artefact were significant effect of electrode position [F(18,162) ϭ 6.591, totally excluded, otherwise data were excluded only in P Ͻ 0.01] and time interval [F(3,27) ϭ 5.169, P Ͻ 0.01], and channels affected by artefact. a significant interaction between these factors [F(54,486) ϭ Data from the extreme frontal electrodes (Fp1 and Fp2) 2.827, P Ͻ 0.01]. This indicates, as is apparent in Fig.  often showed artefact and drift, probably due to their close 1, that the CNV amplitude for control subjects changed proximity to eye and facial musculature. As a result, a large significantly over time but showed a different pattern over proportion of trials from these channels were excluded during time at different electrode positions. Control subjects, manual inspection and, due to the low number of remaining however, showed no significant difference in CNV amplitude trials, these channels were subsequently excluded from further between the two recording sessions [F(1,9) ϭ 0.001, P Ͼ analysis. For all other channels, a mean of 98 Ϯ 36 trials 0.95] and showed no significant interactions involving the were included in the average. factor session [P Ͼ 0.05]. Event-related potentials were averaged time-locked to Reaction time data showed a trend towards longer reaction stimulus presentation and corrected to a baseline consisting times for Parkinson's disease patients when off stimulation of the average amplitude over the period of 1 s before the (mean Ϯ standard deviation ϭ 933 Ϯ 339 ms); reaction time warning stimulus. Go and NoGo trials were averaged together improved when on stimulation (793 Ϯ 230 ms), but was still since the CNV should be equivalent for all trials prior to the longer than that for control subjects (session 1: 690 Ϯ 245 imperative stimulus, as subjects are not aware whether the ms; session 2: 702 Ϯ 284 ms). However, analysis of variance trial is Go or NoGo until the imperative stimulus is given.
showed no significant main effect of subject group [F(1,17) ϭ Mean amplitudes of the event-related potentials were 2.25, P Ͼ 0.05] or session [F(1,17) ϭ 1.71, P Ͼ 0.05] and calculated for each of the four 500 ms intervals between the no significant interaction [F(1,17) ϭ 1.16, P Ͼ 0.05]. It warning and imperative stimuli (0-500, 500-1000, 1000-seems that, since speed of responding was not emphasized 1500 and 1500-2000 ms after the warning stimulus). These in this task and is not necessary for measurement of the mean amplitudes were then examined using analysis of CNV, intertrial variability in reaction times was high for variance with the repeated factors of electrode position (19 all subjects. sites), time interval (four periods) and session/stimulation (first/on compared with second/off), and the between-subjects factor of group (Parkinson's disease compared with control
Control subjects compared with Parkinson's subjects).
In order to examine possible change, CNV amplitudes disease subjects off stimulation
Since there was no significant difference in CNVs for control throughout the course of the study, which may give rise to order effects in the results of Parkinson's disease subjects for subjects over the two recording sessions, data for the two sessions were combined and compared with Parkinson's comparisons of on-and off-stimulation conditions, separate potentials were averaged from approximately the first third disease patients off stimulation, using three-way analysis of variance (factors: electrode position, time interval and subject parietal (P7, P3, Pz, P4, P8) regions. These four electrode groupings were selected, as opposed to examining each group). As reported above for control subjects, there were significant main effects of electrode position [F(18,324) ϭ electrode position independently, to maintain high experimental power and to examine the frontoparietal 7.344, P Ͻ 0.01] and time interval [F(3,54) ϭ 9.770, P Ͻ 0.01] and a significant interaction between these factors distribution rather than the lateralization of the response. The CNV amplitude was found to be significantly greater for [F(54,927) (Fig. 3) . amplitude over time was not significantly different for control subjects compared with Parkinson's disease patients off stimulation.
The overall difference in CNV amplitudes for control
Parkinson's disease subjects off stimulation subjects compared with Parkinson's disease patients off stimulation did not quite reach significance [F(1,18) ϭ 4.064,
compared with on stimulation
The effect of subthalamic nucleus stimulation in Parkinson's P ϭ 0.059]; however, there was a significant interaction between subject group and electrode position [F(18,324) ϭ disease patients was examined by three-way analysis of variance (factors: electrode position, time interval and 2.509, P Ͻ 0.01], indicating that the difference in CNV amplitude for the two subject groups varied significantly stimulation). Again, there were significant main effects of electrode position [F(18,162) ϭ 4.257, P Ͻ 0.01] and time across electrode positions. This difference in CNV topography was examined in more detail, using independent t tests to interval [F(3,27) ϭ 13.592, P Ͻ 0.01] and a significant interaction between these factors [F(54,486) ϭ 2.614, P compare CNV amplitudes for Parkinson's disease and control subjects in frontal (positions F7, F3, Fz, F4, F7), frontocentral Ͻ 0.01]. There was no significant three-way interaction [F(54,486) ϭ 2.180, P Ͼ 0.05] and no significant interaction (FC5, FC1, FC2, FC6) , central (T7, C3, Cz, C4, T8) and compared with stimulation off approached significance [F(1,9) ϭ 4.933, P ϭ 0.053] and there was a significant interaction between stimulation condition and electrode position [F(18,162 ) ϭ 1.823, P Ͻ 0.05], indicating that the effect of stimulation on the CNV amplitude varied significantly across electrode positions. This topographical difference was examined as described above, comparing the difference in CNV amplitude on stimulation and off stimulation at the frontal, frontocentral, central and parietal recording sites using dependent t tests. The CNV amplitude was significantly greater on stimulation compared with off stimulation at the frontal [t(9) ϭ 2.651, P Ͻ 0.05] and frontocentral sites [t(9) ϭ 2.294, P Ͻ 0.05], but was not significantly different at the central [t(9) ϭ 1.749, P Ͼ 0.05] position for patients on stimulation compared with control subjects (Fig. 3) . between time interval and stimulation condition [F(3,27) ϭ Potentials averaged from early stages and late stages of 2.325, P Ͼ 0.05], indicating that the temporal pattern of the both the on and the off condition were also examined. As CNV did not differ significantly between the on-and offwith the overall analysis, there were significant main effects stimulation conditions.
The overall amplitude of the CNV with stimulation on of electrode position [F(18,162) indicates that such patients have no particular problems with easy fatigue or motivation loss that would be expected to indicating that the pattern of CNV amplitudes across time intervals, electrode positions and on compared with off influence results in our study. Electrical stimulation of the subthalamic nucleus produces conditions did not vary significantly between early and late stages of each condition.
an effective lesion (Benazzouz et al., 1995 (Benazzouz et al., , 1996 , theoretically decreasing the excessive outflow of the subthalamic nucleus to the GPi/SNr and thereby decreasing the excessive inhibitory outflow of the GPi/SNr to the
Discussion
Results of this study clearly show an impaired CNV amplitude thalamus, according to the model of Wichmann and DeLong (Wichmann and DeLong, 1996) . As a result, the normally in Parkinson's disease patients compared with control subjects, particularly over the frontal and frontocentral areas, impaired basal ganglia-thalamic outflow to the cortex is increased. Limousin and colleagues have found that electrical which improved significantly during high-frequency bilateral subthalamic nucleus stimulation.
stimulation of the subthalamic nucleus (rather than GPi) is most effective in increasing activation of the frontal cortex, CNV responses generally showed a slowly increasing negative shift, beginning~100-200 ms after warning stimulus particularly the dorsolateral prefrontal cortex , probably because subthalamic nucleus stimulation can presentation, with apparently larger amplitudes over frontal and central recording sites compared with parietal sites. also influence SNr outflow and the dorsolateral prefrontal cortex is a major target of the thalamic projection area of Compared with control subjects, Parkinson's disease subjects, when not receiving subthalamic nucleus stimulation, showed SNr (Ilinksky et al., 1985; Barbas et al., 1991) . Our results have shown similarly that subthalamic nucleus significantly reduced CNV amplitudes over the frontal and frontocentral regions, probably reflecting impaired frontal stimulation increases cortical activity, particularly over the frontal and frontocentral areas, probably reflecting improved cortex activation. This is in accord with previous functional imaging studies showing impaired supplementary motor and frontal cortex function in Parkinson's disease patients; however, these results also extend those reported previously. prefrontal cortex activation in patients with Parkinson's disease (Playford et al., 1992; Jahanshahi et al., 1995) .
The PET study of Limousin and colleagues showed improved cortical activation only when the activity was averaged Such impaired frontal cortex function probably stems from impaired basal ganglia outflow (Owen et al., 1998) , which over a prolonged period of movement performance (a 90 s acquisition period was used) . The normally provides important input to frontal regions via motor and dorsolateral prefrontal basal gangliapresent study has shown that deficits in frontal cortex activation in Parkinson's disease and improvements with thalamocortical circuits (Alexander et al., 1990) .
Bilateral stimulation of the subthalamic nuclei of both subthalamic nucleus stimulation occur during the preparatory phase prior to the initiation of a response. Our results, hemispheres, which greatly improved motor functions, as measured by the UPDRS, increased CNV amplitude therefore, suggest that subthalamic nucleus stimulation in Parkinson's disease improves the cortical activity that significantly over the frontal and frontocentral regions. This is also in accord with previous functional imaging studies underlies cognitive processes associated with the preparation and organization of forthcoming responses. showing increased activation of the supplementary motor area, cingulate cortex and dorsolateral prefrontal cortex during Two recent studies have shown that the early component of the Bereitschaftspotential, which is usually found to be effective stimulation of the subthalamic nucleus . reduced in amplitude in Parkinson's disease (Dick et al., 1989; Cunnington et al., 1995 Cunnington et al., , 1997 , does not change It is unlikely that changes in CNV amplitude across sessions were due only to the order in which conditions were significantly with stimulation of the subthalamic nucleus or GPi (Brown et al., 1999) or following posteroventral tested (on then off). Control subjects showed no significant difference in CNV amplitude across sessions, and Parkinson's pallidotomy (although the late-component amplitude was improved) (Limousin et al., 1999) . This finding is somewhat disease patients showed no significant change in CNV amplitude between the early and late stages of each session.
unexpected given that stimulation of the subthalamic nucleus and of the GPi, as well as posteroventral pallidotomy, have This discounts any significant effects of fatigue or motivation loss on results throughout the period of the study. Parkinson's all been shown to increase the normally impaired activation of the supplementary motor area in Parkinson's disease disease patients also showed no significant difference in task performance, in terms of reaction time, across the two (Samuel et al., 1997; Limousin et al., 1997) , and the supplementary motor area is thought to play a major role in sessions. Similarly, a recent study by Brown and colleagues showed that movement performance (simple and choice the preparation for movement and, hence, in the generation of the early component of the Bereitschaftspotential. reaction times, a pegboard task and finger-tapping speed) for
